Synergistic inhibition of tumour growth in a murine pancreatic cancer has been demonstrated with combined gemcitabine and losartan treatment via VEGF suppression (Noguchi et al, 2009). The gene discussed is VEGFA; the disease is pancreatic neoplasm.